ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 932,96
-0,65%
Dow Jones
38 031,11
0,34%
DAX
17 973,36
0,29%
Brent Oil
83,665
0,15%
Bitcoin
58 363,71
0,22%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Corcept Therapeutics Inc (CORT)

  7. Corcept Therapeutics Inc (CORT) Actualités

CORT Corcept Therapeutics Inc

25,98
2,10 (8,79%)
Avant marché
Dernière mise à jour : 15:25:12
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Corcept Therapeutics Inc CORT NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
2,10 8,79% 25,98 15:25:12
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
23,88
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
01/5/202422:05GLOBECorcept Therapeutics Announces First Quarter Financial..
29/4/202414:00GLOBECorcept Completes Enrollment in Phase 4 CATALYST Trial
24/4/202422:05GLOBECorcept Therapeutics to Announce First Quarter Financial..
22/4/202414:00GLOBECorcept Announces Positive Results From Open-Label Portion..
15/4/202414:00GLOBECorcept Completes Enrollment in Phase 2 DAZALS Trial in..
08/4/202414:00GLOBECorcept Completes Enrollment in Pivotal Phase 3 Rosella..
01/4/202414:00GLOBECorcept Completes Enrollment in Phase 3 Gradient Trial of..
06/3/202403:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202403:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202403:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202403:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202403:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202402:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202423:24EDGAR2Form 144 - Report of proposed sale of securities
22/2/202403:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202402:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202418:12EDGAR2Form 144 - Report of proposed sale of securities
15/2/202422:17EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
15/2/202422:11EDGAR2Form 8-K - Current report
15/2/202422:07GLOBECorcept Therapeutics Announces Fourth Quarter and Full-Year..
15/2/202422:02GLOBECorcept Announces Preliminary Results From Prevalence Phase..
15/2/202421:45EDGAR2Form 144 - Report of proposed sale of securities
14/2/202422:23EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202402:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202402:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202402:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202402:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202401:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202401:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202401:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202422:46EDGAR2Form 5 - Annual statement of changes in beneficial ownership..
13/2/202401:51EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
08/2/202422:05GLOBECorcept Therapeutics to Announce Fourth Quarter and..
02/2/202423:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/2/202420:17EDGAR2Form 144 - Report of proposed sale of securities
29/1/202414:00GLOBECorcept Appoints Roberto Vieira as President, Oncology
22/1/202421:52EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13/1/202402:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/1/202414:06EDGAR2Form 8-K - Current report
08/1/202414:00GLOBECorcept Therapeutics Provides Financial Update and Announces..
05/1/202401:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/1/202417:24EDGAR2Form 144 - Report of proposed sale of securities
02/1/202414:06EDGAR2Form 8-K - Current report
02/1/202414:00GLOBECourt Finds Corcept Therapeutics’ Patents Not Infringed
23/12/202301:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/12/202318:09EDGAR2Form 144 - Report of proposed sale of securities
20/12/202300:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/12/202303:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/12/202302:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/12/202322:34EDGAR2Form 8-K - Current report

Dernières Valeurs Consultées

NASDAQ
CORT
Corcept Therapeutics
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés